(Updated - January 29, 2024 4:27 AM EST)

JPMorgan analyst Eric Joseph upgraded C4 Therapeutics (NASDAQ: CCCC) from Underweight ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE